BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 24315570)

  • 21. A genetic perspective on the proposed inclusion of cannabis withdrawal in DSM-5.
    Verweij KJ; Agrawal A; Nat NO; Creemers HE; Huizink AC; Martin NG; Lynskey MT
    Psychol Med; 2013 Aug; 43(8):1713-22. PubMed ID: 23194657
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cannabis use disorder among people using cannabis daily/almost daily in the United States, 2002-2016.
    Santaella-Tenorio J; Levy NS; Segura LE; Mauro PM; Martins SS
    Drug Alcohol Depend; 2019 Dec; 205():107621. PubMed ID: 31698323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic influences on craving for alcohol.
    Agrawal A; Wetherill L; Bucholz KK; Kramer J; Kuperman S; Lynskey MT; Nurnberger JI; Schuckit M; Tischfield JA; Edenberg HJ; Foroud T; Bierut LJ
    Addict Behav; 2013 Feb; 38(2):1501-1508. PubMed ID: 22481050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic etiology of the common liability to drug dependence: evidence of common and specific mechanisms for DSM-IV dependence symptoms.
    Palmer RH; Button TM; Rhee SH; Corley RP; Young SE; Stallings MC; Hopfer CJ; Hewitt JK
    Drug Alcohol Depend; 2012 Jun; 123 Suppl 1():S24-32. PubMed ID: 22243758
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cannabis dimensionality: dependence, abuse and consumption.
    Beseler CL; Hasin DS
    Addict Behav; 2010 Nov; 35(11):961-9. PubMed ID: 20598807
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Greater Prevalence of Proposed ICD-11 Alcohol and Cannabis Dependence Compared to ICD-10, DSM-IV, and DSM-5 in Treated Adolescents.
    Chung T; Cornelius J; Clark D; Martin C
    Alcohol Clin Exp Res; 2017 Sep; 41(9):1584-1592. PubMed ID: 28667763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic variation in FAAH is associated with cannabis use disorders in a young adult sample of Mexican Americans.
    Melroy-Greif WE; Wilhelmsen KC; Ehlers CL
    Drug Alcohol Depend; 2016 Sep; 166():249-53. PubMed ID: 27394933
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic correlation of antisocial behaviour with alcohol, nicotine, and cannabis use.
    Tielbeek JJ; Vink JM; Polderman TJC; Popma A; Posthuma D; Verweij KJH
    Drug Alcohol Depend; 2018 Jun; 187():296-299. PubMed ID: 29702338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Family-based association analysis of alcohol dependence criteria and severity.
    Wetherill L; Kapoor M; Agrawal A; Bucholz K; Koller D; Bertelsen SE; Le N; Wang JC; Almasy L; Hesselbrock V; Kramer J; Nurnberger JI; Schuckit M; Tischfield JA; Xuei X; Porjesz B; Edenberg HJ; Goate AM; Foroud T
    Alcohol Clin Exp Res; 2014 Feb; 38(2):354-66. PubMed ID: 24015780
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The DSM Guided Cannabis Screen (DSM-G-CS): description, reliability, factor structure and empirical scoring with a clinical sample.
    Alexander D; Leung P
    Addict Behav; 2011 Nov; 36(11):1095-100. PubMed ID: 21741769
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of DSM-IV Opioid Dependence Among Individuals of European Ancestry.
    Brick LA; Micalizzi L; Knopik VS; Palmer RHC
    J Stud Alcohol Drugs; 2019 May; 80(3):319-330. PubMed ID: 31250797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methodological Considerations in Estimation of Phenotype Heritability Using Genome-Wide SNP Data, Illustrated by an Analysis of the Heritability of Height in a Large Sample of African Ancestry Adults.
    Chen F; He J; Zhang J; Chen GK; Thomas V; Ambrosone CB; Bandera EV; Berndt SI; Bernstein L; Blot WJ; Cai Q; Carpten J; Casey G; Chanock SJ; Cheng I; Chu L; Deming SL; Driver WR; Goodman P; Hayes RB; Hennis AJ; Hsing AW; Hu JJ; Ingles SA; John EM; Kittles RA; Kolb S; Leske MC; Millikan RC; Monroe KR; Murphy A; Nemesure B; Neslund-Dudas C; Nyante S; Ostrander EA; Press MF; Rodriguez-Gil JL; Rybicki BA; Schumacher F; Stanford JL; Signorello LB; Strom SS; Stevens V; Van Den Berg D; Wang Z; Witte JS; Wu SY; Yamamura Y; Zheng W; Ziegler RG; Stram AH; Kolonel LN; Le Marchand L; Henderson BE; Haiman CA; Stram DO
    PLoS One; 2015; 10(6):e0131106. PubMed ID: 26125186
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genomic predictors of combat stress vulnerability and resilience in U.S. Marines: A genome-wide association study across multiple ancestries implicates PRTFDC1 as a potential PTSD gene.
    Nievergelt CM; Maihofer AX; Mustapic M; Yurgil KA; Schork NJ; Miller MW; Logue MW; Geyer MA; Risbrough VB; O'Connor DT; Baker DG
    Psychoneuroendocrinology; 2015 Jan; 51():459-71. PubMed ID: 25456346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Probability and correlates of transition from cannabis use to DSM-5 cannabis use disorder: Results from a large-scale nationally representative study.
    Feingold D; Livne O; Rehm J; Lev-Ran S
    Drug Alcohol Rev; 2020 Feb; 39(2):142-151. PubMed ID: 31916333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The validity of DSM-IV cannabis abuse and dependence criteria in adolescents and the value of additional cannabis use indicators.
    Piontek D; Kraus L; Legleye S; Bühringer G
    Addiction; 2011 Jun; 106(6):1137-45. PubMed ID: 21205060
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genome-wide association meta-analysis of age at first cannabis use.
    Minică CC; Verweij KJH; van der Most PJ; Mbarek H; Bernard M; van Eijk KR; Lind PA; Liu MZ; Maciejewski DF; Palviainen T; Sánchez-Mora C; Sherva R; Taylor M; Walters RK; Abdellaoui A; Bigdeli TB; Branje SJT; Brown SA; Casas M; Corley RP; Davey-Smith G; Davies GE; Ehli EA; Farrer L; Fedko IO; Garcia-Martínez I; Gordon SD; Hartman CA; Heath AC; Hickie IB; Hickman M; Hopfer CJ; Hottenga JJ; Kahn RS; Kaprio J; Korhonen T; Kranzler HR; Krauter K; van Lier PAC; Madden PAF; Medland SE; Neale MC; Meeus WHJ; Montgomery GW; Nolte IM; Oldehinkel AJ; Pausova Z; Ramos-Quiroga JA; Richarte V; Rose RJ; Shin J; Stallings MC; Wall TL; Ware JJ; Wright MJ; Zhao H; Koot HM; Paus T; Hewitt JK; Ribasés M; Loukola A; Boks MP; Snieder H; Munafò MR; Gelernter J; Boomsma DI; Martin NG; Gillespie NA; Vink JM; Derks EM
    Addiction; 2018 Nov; 113(11):2073-2086. PubMed ID: 30003630
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DSM-5 cannabis withdrawal syndrome: Demographic and clinical correlates in U.S. adults.
    Livne O; Shmulewitz D; Lev-Ran S; Hasin DS
    Drug Alcohol Depend; 2019 Feb; 195():170-177. PubMed ID: 30361043
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Associations between personality disorders and cannabis use and cannabis use disorder: a population-based twin study.
    Gillespie NA; Aggen SH; Neale MC; Knudsen GP; Krueger RF; South SC; Czajkowski N; Nesvåg R; Ystrom E; Kendler KS; Reichborn-Kjennerud T
    Addiction; 2018 Aug; 113(8):1488-1498. PubMed ID: 29500852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Are genetic variants for tobacco smoking associated with cannabis involvement?
    Agrawal A; Lynskey MT; Kapoor M; Bucholz KK; Edenberg HJ; Schuckit M; Brooks A; Hesselbrock V; Kramer J; Saccone N; Tischfield J; Bierut LJ
    Drug Alcohol Depend; 2015 May; 150():183-7. PubMed ID: 25770649
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of DSM-IV and DSM-5 alcohol, cocaine, opioid, and cannabis use disorders in a largely substance dependent sample.
    Peer K; Rennert L; Lynch KG; Farrer L; Gelernter J; Kranzler HR
    Drug Alcohol Depend; 2013 Jan; 127(1-3):215-9. PubMed ID: 22884164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.